Topics

[Series] Building evidence and measuring clinical outcomes for genomic medicine

20:35 EDT 5 Aug 2019 | The Lancet

Human genomic sequencing has potential diagnostic, prognostic, and therapeutic value across a wide breadth of clinical disciplines. One barrier to widespread adoption is the paucity of evidence for improved outcomes in patients who do not already have an indication for more focused testing. In this Series paper, we review clinical outcome studies in genomic medicine and discuss the important features and key challenges to building evidence for next generation sequencing in the context of routine patient care.

Original Article: [Series] Building evidence and measuring clinical outcomes for genomic medicine

NEXT ARTICLE

More From BioPortfolio on "[Series] Building evidence and measuring clinical outcomes for genomic medicine"

Quick Search

Relevant Topic

DNA sequencing
DNA sequencing is the process of determining the precise order of nucleotides within a DNA molecule. During DNA sequencing, the bases of a small fragment of DNA are sequentially identified from signals emitted as each fragment is re-synthesized from a ...